210 Participants Needed

Community Support Programs for Heart Failure

(UNLOAD-HF Trial)

Recruiting at 1 trial location
CN
PC
MM
Overseen ByMelissa Minotti, MPH, RPSGT, CCRC
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Johns Hopkins University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests the effectiveness of a six-month program for individuals with early heart problems, type 2 diabetes, and obesity. The "Community Champions" group receives problem-solving training, exercise sessions, and support from community health workers. The "Homegrown Heroes" group receives a gym membership and educational newsletters on managing diabetes and heart health. The trial seeks participants in Baltimore City or Hagerstown with low income and early signs of heart issues. Those interested in becoming active with community support may find this trial a good fit. As an unphased trial, it offers a unique opportunity to contribute to innovative research that could enhance community health programs.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that social support and community involvement can greatly enhance health and well-being. This principle is central to the "Community Champions" program. One study found that working with community health workers and attending group support sessions helps people manage their health more effectively. This approach poses no major safety concerns, as it emphasizes behavior change and support rather than medication.

In the "Homegrown Heroes" group, participants receive a YMCA membership and educational newsletters. Exercise and health management education are generally safe and offer well-known benefits. These low-risk activities aim to promote a healthy lifestyle.

Both programs emphasize support and education, which are generally safe methods to improve health. No serious problems have been reported with these activities.12345

Why are researchers excited about this trial?

Researchers are excited about these programs for heart failure because they focus on community-based support and behavioral changes rather than just medication. The "Community Champions" intervention is unique because it includes bi-weekly problem-solving training sessions with groups and support from community health workers, along with a YMCA membership for guided exercise, promoting a holistic approach to health. Meanwhile, the "Homegrown Heroes" program offers educational newsletters on diabetes self-management and heart health, alongside a YMCA membership, making it an accessible option for lifestyle improvement. Both programs emphasize empowering individuals to manage their health actively, which could lead to better long-term outcomes than relying solely on standard medical treatments.

What evidence suggests that this trial's treatments could be effective for heart failure?

Research has shown that community programs, such as "Community Champions," one of the treatment arms in this trial, can lead to small but meaningful improvements in heart health. For example, a study found that participants working with community health workers experienced a slight decrease in heart disease risk. This indicates that regular support and guidance can help individuals better care for their heart.

Similarly, "Homegrown Heroes," another treatment arm in this trial, focuses on education and self-care. Studies have shown that this approach reduces hospital visits for heart failure by almost 12%. This underscores the importance of learning about and managing one's own health to prevent problems.

Both strategies in this trial demonstrate the benefits of community support and education in improving heart health, particularly for individuals with conditions like diabetes and obesity.56789

Who Is on the Research Team?

CN

Chiadi Ndumele, MD, PhD

Principal Investigator

Johns Hopkins School of Medicine

Are You a Good Fit for This Trial?

This trial is for adults with low socioeconomic status, obesity (BMI≥30), type 2 diabetes, and early signs of heart failure in Baltimore City or Hagerstown. Participants must have evidence of cardiac dysfunction and be from specific medical centers in Maryland.

Inclusion Criteria

My BMI is 30 or higher.
I have heart issues shown by tests.
I have type 2 diabetes.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo a 6-month multilevel intervention involving problem-solving training, exercise training, and support from community health workers

6 months
Bi-weekly problem-solving sessions, monthly community health worker visits

Follow-up

Participants are monitored for changes in health outcomes such as hemoglobin A1c, cardiac biomarkers, and self-care measures

6 months
Follow-up assessments at 6 and 12 months

What Are the Treatments Tested in This Trial?

Interventions

  • Community Champions
  • Homegrown Heroes
Trial Overview The study tests a 6-month intervention combining problem-solving training, exercise support by community health workers against just education and access to a community exercise facility. It aims to improve outcomes for those with diabetes at risk of heart failure.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Community ChampionsExperimental Treatment1 Intervention
Group II: Homegrown HeroesActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Johns Hopkins University

Lead Sponsor

Trials
2,366
Recruited
15,160,000+

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Trials
473
Recruited
1,374,000+

Published Research Related to This Trial

Patients with heart failure reported positive perceptions of the care received from the innovative community-based service (CH-CSSS-CSHFP), highlighting the importance of staying home and receiving health-related monitoring.
The study identified key themes such as the desire for connection to the healthcare system, which can inform healthcare professionals in designing more effective services for managing heart failure in the community.
A "basket of care" for heart failure patients managing at home: evaluating a community-based nursing intervention from a patient's perspective.Young, B., Purden, M., Sauvé, N., et al.[2008]
Patient-reported outcomes (PROs) are essential for capturing the real-life impact of heart failure on patients, including their symptoms and quality of life, but are not routinely included in clinical trials.
To improve the relevance of PROs in heart failure research and patient care, there is a need for standardized measures and methods for data collection and analysis, as well as further research to establish clinically important thresholds for these outcomes.
Patient-reported outcome measures and patient engagement in heart failure clinical trials: multi-stakeholder perspectives.Zannad, F., Alikhaani, J., Alikhaani, S., et al.[2023]
A randomized controlled trial involving 9 trained mentors showed that peer support significantly improved heart failure self-care among patients over a 3-month period (P < .05).
Despite the positive impact on self-care, the intervention group experienced a 96% higher heart failure readmission rate compared to the control group, indicating that while peer support can help with self-management, it may not reduce hospitalizations without additional professional education.
Is individual peer support a promising intervention for persons with heart failure?Riegel, B., Carlson, B.[2019]

Citations

Effectiveness of a Community Health Worker Cardiovascular ...For the primary outcome, we observed modest, statistically significant reductions in FRS: −0.8% ±6.2% in the analysis population and −2.0% ±8.5% among those ...
How successful was the use of a community of practice for the ...This study describes the conceptualization, creation, capacity-building and dissemination of a CoP sustained over 9 years, and evaluates its value and impact ...
Community Support Programs for Heart FailureWhat data supports the effectiveness of the treatment Community Champions, Homegrown Heroes for heart failure? Community-based programs and management ...
Clinical Outcomes in Heart Failure Monitoring: A Pooled ...A readmission rate at 32.55% in 3 months is high and demonstrates the scope for improving patient care. Values reported here could help guide ...
Pulmonary artery pressure‐guided heart failure ...The primary efficacy endpoint of the CHAMPION trial was the rate of HF-related hospitalizations. Thus, our primary effectiveness endpoint was ...
An Important Social Determinant of Cardiovascular DiseaseExisting evidence demonstrates a protective effect of social support, social cohesion, and community engagement on overall health and wellbeing.
Community Health Centers Tackling Social Drivers of ...By leveraging health IT systems to identify care opportunities, benchmark clinical outcomes, and integrate SDOH data, CHCs can design and ...
Community champions lead the charge in cardiovascular ...In a groundbreaking initiative, community champions across Kirklees have made significant strides in raising awareness about cardiovascular disease (CVD).
Community champions: A rapid scoping review of ...International evidence on champion-type roles in communicable disease control shows two intervention models. Popular Opinion Leader interventions work by ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security